FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2345534701> ?p ?o ?g. }

• W2345534701 endingPage "89" @default.
• W2345534701 startingPage "677" @default.
• W2345534701 abstract "Osteosarcoma, the most frequent malignant primary bone tumor in pediatric patients is characterized by osteolysis promoting tumor growth. Lung metastasis is the major bad prognosis factor of this disease. Zoledronic Acid (ZA), a potent inhibitor of bone resorption is currently evaluated in phase III randomized studies in Europe for the treatment of osteosarcoma and Ewing sarcoma. The beneficial effect of the liposomal form of Muramyl-TriPeptide-Phosphatidyl Ethanolamine (L-mifamurtide, MEPACT®), an activator of macrophage populations has been demonstrated to eradicate lung metastatic foci in osteosarcoma. The objective of this study was to evaluate the potential therapeutic benefit and the safety of the ZA and L-mifamurtide combination in preclinical models of osteosarcoma, as a prerequisite before translation to patients. The effects of ZA (100 μg/kg) and L-mifamurtide (1 mg/kg) were investigated in vivo in xenogeneic and syngeneic mice models of osteosarcoma, at clinical (tumor proliferation, spontaneous lung metastases development), radiological (bone microarchitecture by microCT analysis), biological and histological levels. No interference between the two drugs could be observed on ZA-induced bone protection and on L-mifamurtide-induced inhibition of lung metastasis development. Unexpectedly, ZA and L-mifamurtide association induced an additional and in some cases synergistic inhibition of primary tumor progression. L-mifamurtide has no effect on tumor proliferation in vitro or in vivo, and macrophage population was not affected at the tumor site whatever the treatment. This study evidenced for the first time a significant inhibition of primary osteosarcoma progression when both drugs are combined. This result constitutes a first proof-of-principle for clinical application in osteosarcoma patients." @default.
• W2345534701 created "2016-06-24" @default.
• W2345534701 creator A5004458586 @default.
• W2345534701 creator A5033486873 @default.
• W2345534701 creator A5038295441 @default.
• W2345534701 creator A5043002838 @default.
• W2345534701 creator A5049291969 @default.
• W2345534701 creator A5057222564 @default.
• W2345534701 creator A5061517866 @default.
• W2345534701 creator A5075730887 @default.
• W2345534701 date "2016-01-01" @default.
• W2345534701 modified "2023-10-03" @default.
• W2345534701 title "L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer." @default.
• W2345534701 cites W1488949116 @default.
• W2345534701 cites W1532955823 @default.
• W2345534701 cites W1547282191 @default.
• W2345534701 cites W1599181382 @default.
• W2345534701 cites W1854116296 @default.
• W2345534701 cites W1938796902 @default.
• W2345534701 cites W1974879801 @default.
• W2345534701 cites W1979552083 @default.
• W2345534701 cites W1984062762 @default.
• W2345534701 cites W1990076994 @default.
• W2345534701 cites W2001291822 @default.
• W2345534701 cites W2013571231 @default.
• W2345534701 cites W2016384953 @default.
• W2345534701 cites W2023204024 @default.
• W2345534701 cites W2039915169 @default.
• W2345534701 cites W2041936982 @default.
• W2345534701 cites W2046945256 @default.
• W2345534701 cites W2050521315 @default.
• W2345534701 cites W2058138047 @default.
• W2345534701 cites W2060688081 @default.
• W2345534701 cites W2079936328 @default.
• W2345534701 cites W2081478283 @default.
• W2345534701 cites W2085450504 @default.
• W2345534701 cites W2088916508 @default.
• W2345534701 cites W2094495788 @default.
• W2345534701 cites W2103405666 @default.
• W2345534701 cites W2106409672 @default.
• W2345534701 cites W2123745849 @default.
• W2345534701 cites W2129260660 @default.
• W2345534701 cites W2137083298 @default.
• W2345534701 cites W2137887836 @default.
• W2345534701 cites W2140835621 @default.
• W2345534701 cites W2142136189 @default.
• W2345534701 cites W2148077417 @default.
• W2345534701 cites W2152081024 @default.
• W2345534701 cites W2152392662 @default.
• W2345534701 cites W2154097649 @default.
• W2345534701 cites W2155271764 @default.
• W2345534701 cites W2162881920 @default.
• W2345534701 cites W2170263258 @default.
• W2345534701 cites W2249234462 @default.
• W2345534701 cites W2329218644 @default.
• W2345534701 cites W2607028219 @default.
• W2345534701 cites W4245103890 @default.
• W2345534701 cites W4246742253 @default.
• W2345534701 cites W4285719527 @default.
• W2345534701 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4851846" @default.
• W2345534701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27152244" @default.
• W2345534701 hasPublicationYear "2016" @default.
• W2345534701 type Work @default.
• W2345534701 sameAs 2345534701 @default.
• W2345534701 citedByCount "13" @default.
• W2345534701 countsByYear W23455347012016 @default.
• W2345534701 countsByYear W23455347012019 @default.
• W2345534701 countsByYear W23455347012020 @default.
• W2345534701 countsByYear W23455347012022 @default.
• W2345534701 countsByYear W23455347012023 @default.
• W2345534701 crossrefType "journal-article" @default.
• W2345534701 hasAuthorship W2345534701A5004458586 @default.
• W2345534701 hasAuthorship W2345534701A5033486873 @default.
• W2345534701 hasAuthorship W2345534701A5038295441 @default.
• W2345534701 hasAuthorship W2345534701A5043002838 @default.
• W2345534701 hasAuthorship W2345534701A5049291969 @default.
• W2345534701 hasAuthorship W2345534701A5057222564 @default.
• W2345534701 hasAuthorship W2345534701A5061517866 @default.
• W2345534701 hasAuthorship W2345534701A5075730887 @default.
• W2345534701 hasConcept C121608353 @default.
• W2345534701 hasConcept C126322002 @default.
• W2345534701 hasConcept C141071460 @default.
• W2345534701 hasConcept C142724271 @default.
• W2345534701 hasConcept C143998085 @default.
• W2345534701 hasConcept C150903083 @default.
• W2345534701 hasConcept C207001950 @default.
• W2345534701 hasConcept C2776326535 @default.
• W2345534701 hasConcept C2777760704 @default.
• W2345534701 hasConcept C2778256501 @default.
• W2345534701 hasConcept C2779013556 @default.
• W2345534701 hasConcept C2781282405 @default.
• W2345534701 hasConcept C502942594 @default.
• W2345534701 hasConcept C673006 @default.
• W2345534701 hasConcept C71924100 @default.
• W2345534701 hasConcept C86803240 @default.
• W2345534701 hasConceptScore W2345534701C121608353 @default.
• W2345534701 hasConceptScore W2345534701C126322002 @default.
• W2345534701 hasConceptScore W2345534701C141071460 @default.

• next